Free tool
FAERS Monitor: Prismasol B22gk 2/0 In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 021703 or its brand name (Prismasol B22gk 2/0 In Plastic Container, Calcium Chloride, Dextrose, Lactic Acid, Magnesium Chloride, Potassium Chloride, Sodium Bicarbonate, Sodium Chloride). Reports on generic versions are filed under their own applications.
Reports
63
Serious
51
81% of reports
Hospitalization
8
Death reported
20
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- haemorrhage17
- death14
- hypotension8
- cardiac arrest6
- device issue6
- acute kidney injury4
- blood pressure decreased4
- haemodialysis complication4
- anaemia3
- haemoglobin decreased3
- multi-organ failure3
- renal failure3
- respiratory failure3
- somnolence3
- thrombocytopenia3
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 12 |
| 2015 | 3 |
| 2016 | 10 |
| 2017 | 4 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 15 |
| 2021 | 5 |
| 2022 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,096 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| haemodialysis complicationSignal | 4 | 8052.8 | 3081.8 | 24,075 |
| multi-organ failureSignal | 3 | 57.9 | 19.2 | 116 |
| haemorrhageSignal | 17 | 54.3 | 36.2 | 841 |
| cardiac arrestSignal | 6 | 24.3 | 11.3 | 112 |
| device issueSignal | 6 | 22.3 | 10.4 | 102 |
| blood pressure decreasedSignal | 4 | 20.1 | 7.8 | 55 |
| respiratory failureSignal | 3 | 13.7 | 4.6 | 24 |
| hypotensionSignal | 8 | 13.3 | 7.0 | 80 |
| haemoglobin decreasedSignal | 3 | 9.8 | 3.2 | 16 |
| thrombocytopeniaSignal | 3 | 9.0 | 3.0 | 14 |
| acute kidney injurySignal | 4 | 8.7 | 3.4 | 20 |
| renal failureSignal | 3 | 7.5 | 2.5 | 11 |
| deathSignal | 14 | 5.4 | 3.4 | 48 |
| anaemiaSignal | 3 | 5.3 | 1.7 | 7 |
| somnolenceSignal | 3 | 5.0 | 1.6 | 6 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.